• Product nameAnti-MUM1 antibody [EPR5653]
    See all MUM1 primary antibodies
  • Description
    Rabbit monoclonal [EPR5653] to MUM1
  • Tested applicationsSuitable for: WB, IP, IHC-Pmore details
    Unsuitable for: Flow Cyt or ICC
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide, corresponding to residues from the N-terminus of Human MUM1.

  • Positive control
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

    A trial size is available to purchase for this antibody.

    Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.


Associated products


Our Abpromise guarantee covers the use of ab124691 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Detects a band of approximately 52 kDa (predicted molecular weight: 52 kDa).
IP 1/10 - 1/100.
IHC-P 1/100 - 1/250. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
  • Application notesIs unsuitable for Flow Cyt or ICC.
  • Target

    • FunctionTranscriptional activator. Binds to the interferon-stimulated response element (ISRE) of the MHC class I promoter. Binds the immunoglobulin lambda light chain enhancer, together with PU.1. Probably plays a role in ISRE-targeted signal transduction mechanisms specific to lymphoid cells.
    • Tissue specificityLymphoid cells.
    • Involvement in diseaseDefects in IRF4 are a cause of multiple myeloma (MM) [MIM:254500]. MM is a malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. Note=A chromosomal aberration involving IRF4 is found in multiple myeloma. Translocation t(6;14)(p25;q32) with the IgH locus.
    • Sequence similaritiesBelongs to the IRF family.
      Contains 1 IRF tryptophan pentad repeat DNA-binding domain.
    • Cellular localizationNucleus.
    • Information by UniProt
    • Database links
    • Alternative names
      • Interferon regulatory factor 4 antibody
      • IRF 4 antibody
      • IRF-4 antibody
      • Irf4 antibody
      • IRF4_HUMAN antibody
      • LSIRF antibody
      • Lymphocyte specific interferon regulatory factor antibody
      • Lymphocyte specific IRF antibody
      • Lymphocyte-specific interferon regulatory factor antibody
      • Multiple myeloma oncogene 1 antibody
      • MUM 1 antibody
      • MUM1 antibody
      • NF EM5 antibody
      • NF-EM5 antibody
      • NFEM5 antibody
      • PU.1 interaction partner antibody
      • Sfpi1/PU.1 interaction partner antibody
      • Transcriptional activator PIP antibody
      see all

    Anti-MUM1 antibody [EPR5653] images

    • All lanes : Anti-MUM1 antibody [EPR5653] (ab124691) at 1/1000 dilution

      Lane 1 : Ramos cell lysate
      Lane 2 : HuT 78 cell lysate
      Lane 3 : IM 9 cell lysate

      Lysates/proteins at 10 µg per lane.

      Goat anti-Rabbit HRP at 1/2000 dilution

      Predicted band size : 52 kDa
    • ab124691, at 1/100, staining MUM1 in paraffin-embedded Human colon tissue by Immunohistochemistry.
    • ab124691, at 1/100, staining MUM1 in paraffin-embedded Human tonsil tissue by Immunohistochemistry.
    • Immunohistochemical analysis of dog spleen tissue, staining MUM1 with ab124691.

      Tissue was fixed with formaldehyde and blocked with 2.5% serum for 30 minutes at 25°C; antigen retrieval was by heat mediation in a TRIS-EDTA buffer (pH 9). Samples were incubated with primary antibody (1/50 in PBS plus 1X casein) for 1 hour 30 minutes at 37°C. An undiluted HRP-conjugated horse anti-rabbit polyclonal IgG was used as the secondary antibody.

      See Abreview

    • Equilibrium disassociation constant (KD)
      Learn more about KD

      Click here to learn more about KD

    References for Anti-MUM1 antibody [EPR5653] (ab124691)

    This product has been referenced in:
    • Vieyra-Garcia PA  et al. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides. Clin Cancer Res 22:3328-39 (2016). IHC-P ; Human . Read more (PubMed: 26851186) »

    See 1 Publication for this product

    Product Wall

    Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
    Sample Dog Tissue sections (spleen)
    Specification spleen
    Fixative Formaldehyde
    Antigen retrieval step Heat mediated - Buffer/Enzyme Used: Tris-EDTA (pH 9.0)
    Permeabilization No
    Blocking step Serum as blocking agent for 30 minute(s) · Concentration: 2.5% · Temperature: 25°C

    Abcam user community

    Verified customer

    Submitted Nov 30 2012